LevelStock.com: MusclePharm Adds Former U.S. Assistant Surgeon General to Its Team as Chief Scientific Director

MusclePharm Corporation (OTCBB:MSLP), a fast-growing nutritional supplement company with a proprietary formulation used in eight performance products, announced today that the former Assistant Surgeon General Dr. Roscoe M. Moore, Jr. joins MusclePharm as its Chief Scientific Director.

"We are honored and excited that Dr. Roscoe M. Moore, Jr. is joining our Company as Chief Scientific Director. His experience and knowledge in the medical field and his background within the FDA and US Public Health Services will be a tremendous asset to MusclePharm. In addition to overseeing our next generation of product offerings, he will assist in our path towards insurance reimbursement for our Re-Con product for HIV patients suffering from involuntary weight loss and catabolic cachexia, which is a very large market," commented Cory Gregory, President of MusclePharm. "Dr. Moore's decision to join MusclePharm is a reinforcement of the quality and effectiveness of our products and our strong research and developments efforts."

MusclePharm presented at the XVIII International Aids Conference in Vienna, Austria sponsored by NAPWA and The AIDS Institute on Thursday, July 22, 2010 on the use of Re-Con, which was enthusiastically received by an audience of 200+ people including several leading clinicians and researchers and top government representatives. The Company presented evidence that its product, Re-Con, has shown clinical attributes that dramatically addresses the involuntary weight loss and catabolic cachexia in HIV patients on HAART (highly active antiretroviral therapy).

Dr. Roscoe M. Moore, Jr. commented, ""Unintentional and involuntary weight loss in people living with HIV/AIDS have long been recognized as a serious consequence of this disease. The nutritional requirements among persons undergoing antiretroviral therapy have not been adequately and systematically addressed. Therapeutic nutritional supplementation products, like those provided by MusclePharm, are essential in maintaining the health status of HIV/AIDS patients. I look forward to joining MusclePharm in order to provide the most effective evidence-based approach to assure appropriate and adequate therapeutic nutritional supplementation to mitigate the impact and progression of wasting syndrome in HIV/AIDS patients."

New York and other state Medicaid programs, as well as AIDS drug assistance programs and nation-wide Veterans Administration therapeutic formularies all recognize the value of therapeutic nutritional supplementation interventions for the treatment of catabolic cachexia, the prognostic markers of which are associated with loss of appetite, uncontrolled diarrhea, macro and micronutrient deficiencies, abnormal cytokine presentation, proinflammatory oxidative stress and decreased caloric intake.

Several reports of observed clinical improvement in U.S. AIDS patients in outpatient settings indicate that Re-Con in conjunction with Medicaid approved sources of whey protein and HMB intake have dramatically increased lean body mass in patients diagnosed with catabolic cachexia, with definitive correlations to the prevention of the onset of HIV drug resistance. Clinical studies to further examine this phenomenon are now being planned by leading clinicians and community advocates in multi-site trials across the U.S. and Europe. A proposal for the federal facilitation of these studies is being prepared for the Adult AIDS Clinical Trials Group at the National Institute of Allergy and Infectious and Diseases, National Institutes of Health.

About MusclePharm Corporation

MusclePharm's top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside. Headquartered in Denver, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere. To date, the company has developed eight products: ASSAULT , BATTLE FUEL , BULLET PROOF , COMBAT POWDER , RECON , SHRED MATRIX , and MUSCLEGEL . Two additional products are due in stores in 2010. MusclePharm products offer up to twice as much of the active ingredients per serving as competing products and incorporate a proprietary mix of ingredients not available elsewhere, such as Suma root- the "Russian Secret." Suma is a natural, performance-boosting, strength-and muscle-building herbal derivative that has been used for years by top Russian athletes.

For more information, please visit www.musclepharm.com.

Forward-looking Statements

MusclePharm Corporation believes the information set forth in this Press Release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in "Risk Factors" in Item 2.02 of the Company's Form 8-K dated February 18, 2010, which has been filed with the Securities and Exchange Commission.

About LevelStock.com

We are an investor community and investors relations website specializing in emerging growth stocks in today's Hot Sectors and providing a platform of services for SmallCap, MicroCap, NanoCap Companies.

We encourage everyone to join our social media sites:

Free Subscription For Our Newsletters: http://www.levelstock.com/

FaceBook: http://www.facebook.com/group.php?gid=283660480870

Twitter: http://twitter.com/levelstock

LevelStock.com is not a registered investment advisor or broker-dealer. The information here is believed to be reliable, but not guaranteed to be accurate by LevelStock.com Please be advised that the information contained may or may not be complete and is solely for informational purposes only. Please read our full disclaimer for complete risks and disclosures http://levelstock/news.php?viewStory=19

CONTACT INFO: LevelStock.com 288 Grove Street Suite 181, Braintree, MA 02184

CONTACT: LevelStock.com e-mail: support@levelstock.com